Atomistry » Sodium » PDB 7pfi-7q77 » 7q5f
Atomistry »
  Sodium »
    PDB 7pfi-7q77 »
      7q5f »

Sodium in PDB 7q5f: Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2.

Enzymatic activity of Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2.

All present enzymatic activity of Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2.:
3.4.22.69;

Protein crystallography data

The structure of Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2., PDB code: 7q5f was solved by E.Costanzi, N.Demitri, P.Storici, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 49.43 / 1.72
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 67.866, 100.441, 103.631, 90, 90, 90
R / Rfree (%) 17.2 / 19.6

Other elements in 7q5f:

The structure of Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2. also contains other interesting chemical elements:

Chlorine (Cl) 6 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2. (pdb code 7q5f). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2., PDB code: 7q5f:

Sodium binding site 1 out of 1 in 7q5f

Go back to Sodium Binding Sites List in 7q5f
Sodium binding site 1 out of 1 in the Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2.


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of F2F-2020216-01X Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2. within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Na405

b:38.3
occ:1.00
 OD1 B:ASP263 2.0 48.0 1.0
OD1 B:ASN221 2.2 30.9 1.0
O B:HOH520 2.3 29.1 1.0
O B:PHE223 2.4 26.0 1.0
O B:ASN221 2.7 25.2 1.0
O B:ASP263 3.0 33.9 1.0
HB3 B:ALA266 3.0 42.4 1.0
H B:ASN221 3.1 40.0 1.0
H B:PHE223 3.2 31.3 1.0
CG B:ASP263 3.3 48.5 1.0
CG B:ASN221 3.3 29.5 1.0
C B:ASN221 3.4 26.1 1.0
C B:PHE223 3.5 30.1 1.0
N B:PHE223 3.5 26.1 1.0
HA B:ASP263 3.6 50.7 1.0
C B:ASP263 3.8 39.5 1.0
N B:ASN221 3.9 33.3 1.0
CB B:ALA266 3.9 35.4 1.0
HB1 B:ALA266 4.0 42.4 1.0
CA B:ASN221 4.0 31.2 1.0
CA B:PHE223 4.0 27.3 1.0
CA B:ASP263 4.0 42.3 1.0
OG B:SER267 4.1 32.2 1.0
H B:SER267 4.1 36.8 1.0
OD2 B:ASP263 4.1 51.8 1.0
C B:ARG222 4.1 26.2 1.0
HB2 B:PHE223 4.2 32.3 1.0
HD22 B:ASN221 4.2 37.7 1.0
N B:ARG222 4.2 26.7 1.0
ND2 B:ASN221 4.2 31.4 1.0
CB B:ASP263 4.2 45.4 1.0
CB B:ASN221 4.3 28.2 1.0
HA B:THR224 4.3 38.1 1.0
N B:SER267 4.4 30.7 1.0
HG B:SER267 4.4 38.7 1.0
HB2 B:ALA266 4.4 42.4 1.0
CA B:ARG222 4.6 25.9 1.0
N B:THR224 4.6 29.4 1.0
HA B:ARG222 4.6 31.1 1.0
CB B:PHE223 4.7 27.0 1.0
C B:ALA266 4.7 38.1 1.0
HB2 B:ASN221 4.8 33.8 1.0
HB3 B:ASP263 4.8 54.5 1.0
HA B:LEU220 4.8 37.3 1.0
HG23 B:ILE259 4.8 52.9 1.0
CA B:ALA266 4.8 35.5 1.0
HA B:PHE223 4.9 32.7 1.0
H B:ARG222 4.9 32.0 1.0
O B:ARG222 4.9 26.8 1.0
H B:ALA266 4.9 37.1 1.0
HB2 B:ASP263 4.9 54.5 1.0
N B:MET264 4.9 35.7 1.0
HA B:SER267 4.9 34.7 1.0
HA B:MET264 4.9 38.4 1.0
HA B:ASN221 4.9 37.4 1.0
CA B:THR224 4.9 31.8 1.0
HB3 B:ASN221 5.0 33.8 1.0

Reference:

S.Pelliccia, C.Cerchia, F.Esposito, R.Cannalire, A.Corona, E.Costanzi, M.Kuzikov, P.Gribbon, A.Zaliani, M.Brindisi, P.Storici, E.Tramontano, V.Summa. Easy Access to Alpha-Ketoamides As Sars-Cov-2 and Mers M Pro Inhibitors Via the Padam Oxidation Route. Eur.J.Med.Chem. V. 244 14853 2022.
ISSN: ISSN 0223-5234
PubMed: 36332546
DOI: 10.1016/J.EJMECH.2022.114853
Page generated: Tue Oct 8 18:36:03 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy